Snapshot from Jul 07, 2026 at 01:18 UTC. For live data and tracking: View Live
Entities / Companies / Mapp Biopharmaceutical
Entity

Mapp Biopharmaceutical

Tracked across 2 events · 75 articles · First seen Apr 20, 2026 · Last active Jul 05, 2026

Sentiment
45
Attention
6
Events
2
Relationships
22
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
Events (2)
6 40
Tech
Ebola Treatment Trial Begins DRC
Impact: Mapp Biopharmaceutical developed MBP134, an experimental monoclonal antibody treatment being tested in the Ebola clinical trial. The United States government has funded research for this drug.
Apr 20, 2026 · 67 articles
6 50
Tech
WHO Lists Bundibugyo Ebola Test
Impact: Mapp Biopharmaceutical's experimental MBP134 antibody is being evaluated in a treatment trial for the Bundibugyo Ebola outbreak in the Democratic Republic of the Congo, either as a standalone treatment or in combination with Gilead Sciences' remdesivir.
Jul 02, 2026 · 8 articles
Key Actions (2)
55 Mapp Biopharmaceutical developed MBP 134Ebola Treatment Trial Begins DRC
50 Mapp Biopharmaceutical enrolled patient Democratic Republic of the CongoWHO Lists Bundibugyo Ebola Test
Relationships (22)
Gilead Sciences ↔ Mapp Biopharmaceutical
Gilead Sciences ↔ Mapp Biopharmaceutical
Serum Institute of India ↔ Mapp Biopharmaceutical
Serum Institute of India ↔ Mapp Biopharmaceutical
International AIDS Vaccine Initiative ↔ Mapp Biopharmaceutical
International AIDS Vaccine Initiative ↔ Mapp Biopharmaceutical
Merck & Co. ↔ Mapp Biopharmaceutical
Merck & Co. ↔ Mapp Biopharmaceutical
Regeneron Pharmaceuticals ↔ Mapp Biopharmaceutical
Regeneron Pharmaceuticals ↔ Mapp Biopharmaceutical
Tedros Adhanom Ghebreyesus ↔ Mapp Biopharmaceutical
Tedros Adhanom Ghebreyesus ↔ Mapp Biopharmaceutical
Democratic Republic of the Congo ↔ Mapp Biopharmaceutical
Democratic Republic of the Congo ↔ Mapp Biopharmaceutical
World Health Organization ↔ Mapp Biopharmaceutical
World Health Organization ↔ Mapp Biopharmaceutical
Uganda ↔ Mapp Biopharmaceutical
Uganda ↔ Mapp Biopharmaceutical
United States — Centers for Disease Control and Prevention ↔ Mapp Biopharmaceutical
United States — Centers for Disease Control and Prevention ↔ Mapp Biopharmaceutical
United States ↔ Mapp Biopharmaceutical
United States ↔ Mapp Biopharmaceutical
ERGEN INTELLIGENCE
Track Mapp Biopharmaceutical live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.